3ohl
From Proteopedia
(Difference between revisions)
| Line 3: | Line 3: | ||
<StructureSection load='3ohl' size='340' side='right'caption='[[3ohl]], [[Resolution|resolution]] 2.36Å' scene=''> | <StructureSection load='3ohl' size='340' side='right'caption='[[3ohl]], [[Resolution|resolution]] 2.36Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[3ohl]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/ | + | <table><tr><td colspan='2'>[[3ohl]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3OHL OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=3OHL FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=OHL:N-HYDROXY-N~2~-[(4-METHOXYPHENYL)SULFONYL]-N~2~-(PYRIDIN-4-YLMETHYL)GLYCINAMIDE'>OHL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.36Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=OHL:N-HYDROXY-N~2~-[(4-METHOXYPHENYL)SULFONYL]-N~2~-(PYRIDIN-4-YLMETHYL)GLYCINAMIDE'>OHL</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> | |
| - | + | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ohl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ohl OCA], [https://pdbe.org/3ohl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ohl RCSB], [https://www.ebi.ac.uk/pdbsum/3ohl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ohl ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=3ohl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=3ohl OCA], [https://pdbe.org/3ohl PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=3ohl RCSB], [https://www.ebi.ac.uk/pdbsum/3ohl PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=3ohl ProSAT]</span></td></tr> | ||
</table> | </table> | ||
== Disease == | == Disease == | ||
| - | + | [https://www.uniprot.org/uniprot/MMP3_HUMAN MMP3_HUMAN] Defects in MMP3 are the cause of susceptibility to coronary heart disease type 6 (CHDS6) [MIM:[https://omim.org/entry/614466 614466]. A multifactorial disease characterized by an imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. Decreased capacity of the coronary vessels is often associated with thickening and loss of elasticity of the coronary arteries. Note=A polymorphism in the MMP3 promoter region is associated with the risk of coronary heart disease and myocardial infarction, due to lower MMP3 proteolytic activity and higher extracellular matrix deposition in atherosclerotic lesions.<ref>PMID:8662692</ref> <ref>PMID:12477941</ref> | |
== Function == | == Function == | ||
| - | + | [https://www.uniprot.org/uniprot/MMP3_HUMAN MMP3_HUMAN] Can degrade fibronectin, laminin, gelatins of type I, III, IV, and V; collagens III, IV, X, and IX, and cartilage proteoglycans. Activates procollagenase. | |
==See Also== | ==See Also== | ||
| Line 20: | Line 19: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
| - | + | [[Category: Kowatz T]] | |
| - | [[Category: Kowatz | + | [[Category: Naismith JH]] |
| - | [[Category: Naismith | + | |
| - | + | ||
| - | + | ||
Current revision
catalytic domain of stromelysin-1 in complex with N-Hydroxy-2-(4-methoxy-N-(pyridine-3-ylmethyl)phenylsulfonamido)acetamide
| |||||||||||
